Obroty Zmiana Data
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
Chugai Pharma JPY 404.7B 63.1B 2026-09
Daiichi Sankyo JPY 592.49B 17.75B 2026-09
DBV Technologies USD 1.6M 955K 2026-09
Enanta Pharmaceuticals USD 16.96M 50.68M 2024-12
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
Glaxosmithkline GBP 8.89B 1.2B 2026-09
Incyte USD 1.56B 110M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
Karyopharm Therapeutics USD 35.07M 987K 2026-03
Neurocrine Biosciences USD 1.12B 161M 2026-09
Novavax USD 147.14M 76.69M 2025-12
PTC Therapeutics USD 357.8M 3.2M 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
Vertex Pharmaceuticals USD 3.44B 110M 2026-09